Re-appointment of Dr. Kausalya Santhanam (DIN:06999168) as Independent Director of the Company for the second term of five years subject to approval of shareholders of the Company
Strides Pharma Science: Announcement under Regulation 30 (LODR)-Change in Directorate
October 24, 2024
Download PDF
Strides Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month